Seeking Alpha

Sanofi-Aventis (SNY) discontinues clinical trials of its controversial anti-obesity drug which...

Sanofi-Aventis (SNY) discontinues clinical trials of its controversial anti-obesity drug which had been linked to psychiatric side effects. Separately, Pfizer (PFE) and Merck (MRK) have both abandoned similar drugs.
Comments (0)
Be the first to comment
DJIA (DIA) S&P 500 (SPY)
ETF Hub
ETF Screener: Search and filter by asset class, strategy, theme, performance, yield, and much more
ETF Performance: View ETF performance across key asset classes and investing themes
ETF Investing Guide: Learn how to build and manage a well-diversified, low cost ETF portfolio
ETF Selector: An explanation of how to select and use ETFs